Associate
Antoinette's technical experience includes synthetic organic chemistry (natural product synthesis, catalysis, and development of new reaction methodologies), medicinal chemistry, and chemical biology. Prior to joining Finnegan, she worked as a postdoctoral fellow at Massachusetts General Hospital/Harvard Medical School. Her research focused on the synthesis and development of selective class IIa HDAC inhibitors as tool compounds or anticancer drugs, in addition to aminoacyl-tRNA synthetase inhibitors as antimalarial drugs. She also worked as a postdoctoral fellow at The University of Chicago, where her research was dedicated to the development of new reaction methodologies, including the spirocyclization of (ox)indole bisnucleophiles and homologation reactions of masked acyl cyanides.
Antoinette earned her doctorate in chemistry from Northwestern University. Her graduate research explored the synthesis of flavanoid small-molecule inhibitors of both prostate cancer motility and invasion.
Event
Introduction to Patents and Patent Law Introduction to Patents and Patent Law
February 7, 2024
Virtual
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.